Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acute abdomen
antiphospholipid antibody syndrome
atrial septal aneurysm
cerebral embolism
cerebral venous thrombosis
cerebral venous thrombosis, recurrent
cerebrovascular accident
cerebrovascular accident, cryptogenic
cerebrovascular accident, silent
cerebrovascular accident, women
cerebrovascular accident, young adult
diplopia
dural sinus thrombosis
echocardiogram
edema, leg
embolism, paradoxical
gender
high altitude sickness
lateral rectus palsy
May-Thurner syndrome
mountain climbing
MRI
MRI, abnormal
MRI, pelvis
MRI, venography
ophthalmoplegia
oral contraceptives
oral contraceptives, cerbrovascular disease and
pain, abdominal
patent foramen ovale
pelvic deep venous thrombosis
persistent eustacian valve
polycythemia, primary
primary thrombocythemia
risk factors
sports medicine, neurology of
superior sagittal sinus thrombosis
thrombophlebitis
transient ischemic attack
venous thrombosis, mesenteric
venous thrombosis, non-cerebral
workup
Showing articles 700 to 750 of 6496 << Previous Next >>

Cooling for Acute Ischemic Brain Damage (COOL AID)
Stroke 32:1847-1854, Krieger,D.W.,et al, 2001

Sustained Bilateral Hemodynamic Benefit of Contralateral Carotid Endarterectomy in Patients with Symptomatic Internal Carotid Artery Occlusion
Stroke 32:728-734, Rutgers,D.R.,et al, 2001

Stroke Magnetic Resonance Imaging Within 6 Hours After Onset of Hyperacute Cerebral Ischemia
Ann Neurol 49:460-469, Schellinger,P.D.,et al, 2001

Intravenous tPA for Ischemic Stroke Team Performance Over Time, Safety, and Efficacy in a Single-Center, 2-Year Experience
Stroke 32:1074-1078, Koennecke,H.,et al, 2001

Benefits of Perfusion MR Imaging Relative to Diffusion MR Imaging in the Diagnosis and Treatment of Hyperacute Stroke
AJNR 22:915-921,806, Sunshine,J.L.,et al, 2001

Efficacy of MR Angiography in the Detection and Characterization of Occlusive Disease in the Vertebrobasilar System
J Comput Assist Tomogr 25:458-465, Bhadelia,R.A.,et al, 2001

Stroke Prevention and Treatment in Sickle Cell Disease
Arch Neurol 58:565-568, Adams,R.J., 2001

Why Are Stroke Patients Excluded from TPA Therapy?
Neurol 56:1015-1020, Barber,P.A.,et al, 2001

Cerebral Sinus Thrombosis with Tamoxifen
Neurol 56:1113-1114, Finelli,P.F. & Schauer,P.K., 2001

Intraarterial Thrombolysis: Ready for Prime Time?
AJNR 22:55-58, Executive Committee of the ASITN, 2001

Improved Cerebrovascular Patency Following Therapy in Patients with Sickle Cell Disease: Initial Results in 4 Patients Who Received HLA-Identical Hematopoietic Stem Cell Allografts
Ann Neurol 49:222-229, Steen,R.G.,et al, 2001

Diffusion-weighted Imaging Patterns of Brain Damage Associated with Cerebral Venous Thrombosis
AJNR 22:261-268, Ducreux,D.,et al, 2001

Combined Intraarterial/Intravenous Thrombolysis for Acute Ischemic Stroke
AJNR 22:352-358, Keris,V.,et al, 2001

Venous Thromboembolism After Acute Stroke
Stroke 32:262-267, Kelly,J.,et al, 2001

Deterioration Following Improvement with tPA Therapy: Carotid Thrombosis and Reocclusion
Neurol 56:568-570, Burgin,W.S. &Alexandrov,A.V., 2001

Cerebrovascular Manifestations in 321 Cases of Hereditary Hemorrhagic Telangiectasia
Stroke 32:877-882, Maher,C.O.,et al, 2001

Cerebral Venous Thrombosis Presenting as Acute Visual Loss
Br J Ophthalmol 85:1139, Ko,Y.-C.,et al, 2001

Combined Intravenous and Intra-Arterial Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke
Stroke 31:2552-2557, Ernst,R.,et al, 2000

Cerebral Venous Thrombosis: Anticoagulants or Thrombolyic Therapy?
JNNP 69:427-430, Benamer,H.T.S. & Bone,I., 2000

Pulmonary Arteriovenous Malformations
Neurol 55:959-964, Moussouttas,M.,et al, 2000

Stroke and Pregnancy
Stroke 31:2948-2951, Jaigobin,C. & Silver,F.L., 2000

Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Stroke 31:2920-2924, Chapman,K.M.,et al, 2000

Corpus Callosum Infarcts with Atypical Clinical and Radiologic Presentations
AJNR 21:1876-1880, Kasow,D.L.,et al, 2000

Subarachnoid Haemorrhage Treated with Anticoagulants
Lancet 356:1818, Ciccone,A.,et al, 2000

Selective Infusion of Urokinase and Thrombectomy in the Treatment of Acute Cerebral Sinus Thrombosis
AJNR 21:143-145, Novak,Z.,et al, 2000

Superior Sagittal Sinus Thrombosis Due to Lithium:Local Urokinase Thrombolysis Treatment
Neurol 54:532-533, Wasay,M.,et al, 2000

Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Patients Aged 80 Years and Older, The tPa Stroke Survey Experience
Stroke 31:370-375, Tanne,D.,et al, 2000

Treating Acute Stroke Patients with Intravenous tPA, The OSF Stroke Network Experience
Stroke 31:77-81, Wang,D.Z.,et al, 2000

Cerebral Venous Thrombosis Associated with Epoetin Alfa Therapy
Arch Neurol 57:260-262, Finelli,P.F.&Carley,M.D., 2000

Diffusion- and Perfusion-Weighted MR Imaging of Dural Sinus Thrombosis
AJNR 21:68-73, Manzione,J.,et al, 2000

Neurological Emergencies: Acute Stroke
JNNP 68:277-288, Davenport,R. & Dennis,M., 2000

Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute Stroke
JAMA 283:1145-1150,1189, Albers,G.W.,et al, 2000

Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke
JAMA 283:1151-1158,1189, Katzan,I.L.,et al, 2000

Cerebral Sinus Thrombosis Diagnosed by MRI and MR Venography in Cancer Patients
Neurol 54:1222-1226, Raizer,J.J.&DeAngelis,L.M., 2000

Intravenous tPA in Acute Ischemic Stroke Related to Internal Carotid Artery Dissection
Neurol 54:2159-2161, Derex,L.,et al, 2000

Monitoring Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis for Acute Ischemic Stroke With Diffusion and Perfusion MRI
Stroke 31:1318-1328, Schellinger,P.D.,et al, 2000

Risk Factors for Peripartum and Postpartum Stroke and Intracranial Venous Thrombosis
Stroke 31:1274-1282, Lanska,D.J.&Kryscio,R.J., 2000

Endovascular Treatment of Dural Sinus Thrombosis With Rheolytic Thrombectomy and Intra-Arterial Thrombolysis
Stroke 31:1420-1425, Chow,K.,et al, 2000

Validity and Reliability of a Quantitative Computed Tomography Score in Predicting Outcome of Hyperacute Stroke Before Thrombolytic Therapy
Lancet 355:1670-1674, Barber,P.A.,et al, 2000

Intravenous Ancrod for Treatment of Acute ischemic Stroke
JAMA 283:2395-2403, Sherman,D.G.,et al, 2000

Ancrod-Is Snake Venom an Antidote for Stroke
JAMA 283:2440-2441, Mayberg,M.R.&Furlan,A., 2000

Transcranial Doppler Ultrasound Criteria for Recanalization After Thrombolysis for Middle Cerebral Artery Stroke
Stroke 31:1128-1132, Burgin,W.S.,et al, 2000

Comparison of Diffusion-Weighted MRI and CT in Acute Stroke
Neurol 54:1557-1561,1548,1549,1552, Lansberg,M.G.,et al, 2000

New magnetic Resonance Imaging Methods for Cerebrovascular Disease: Emerging Clinical Applications
Ann Neurol 47:559-570, Neumann-Haefelin,T.,et al, 2000

Impact on Stroke Subtype Diagnosis of Early Diffusion-Weighted Magnetic Resonance Imaging and Magnetic Resonance Angiography
Stroke 31:1081-1089, Lee,L.J.,et al, 2000

Magnetic Resonance Venography in Idiopathic Pseudotumor Cerebri
J Neuro-Ophthal 20:12-13, Lee,A.G.&Brazis,P.W., 2000

Feasibility and Practicality of MR Imaging of Stroke in the Management of Hyperacute Cerebral Ischemia
AJNR 21:1184-1189, 1177, Schellinger,P.D. et al, 2000

Stroke Mimicry: Four Cases Eligible for Tissue Plasminogen Activator
The Neurologist 6:220-223, Kirshner, H.S., 2000

Facial Palsy in Cerebral Venous Thrombosis
Stroke 31:1766-1769, Straub,J. et al, 2000

Intracranial Vertebrobasilar Stenosis: Angioplasty and Follow-Up
AJNR 21:1293-1301, Nahser,H.C. et al, 2000



Showing articles 700 to 750 of 6496 << Previous Next >>